Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura
Year: 2024
Type: article
Study design: Observational Study
Source: Annals of Hematology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4402447428
